Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2012 New Report


Naperville, IL -- (SBWire) -- 02/11/2013 --Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012 provides data on the Kuhnil Pharmaceutical Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from databases, Kuhnil Pharmaceutical Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Kuhnil Pharmaceutical Co., Ltd. and industry-specific third party sources.


- Kuhnil Pharmaceutical Co., Ltd. - Brief Kuhnil Pharmaceutical Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Kuhnil Pharmaceutical Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Kuhnil Pharmaceutical Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Kuhnil Pharmaceutical Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Kuhnil Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Kuhnil Pharmaceutical Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Kuhnil Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Kuhnil Pharmaceutical Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Kuhnil Pharmaceutical Co., Ltd. and identify potential opportunities in those areas.

To view table of contents for this market report please visit:

Media Relations Contact

Web Master

View this press release online at: http://rwire.com/205637